Ahmed Diab

Huge congratulations to Dr Jennifer Douglas @Penn_ENT for her P50 grant with collaborators @ Monell Chemical Senses Center! Incredible accomplishment for this surgeon:scientist star.

It was a privilege to present today at the 9th annual DDR Summit in Boston , representing the @PennCancer team advancing translational science and clinical trials for HPV+ head and neck cancer @DiabLabPenn @DrNickLukens @LovaSunMD

I’m coming to New Orleans in April to give a talk and would love to see about bringing our science to other institutions in the area. Anyone have opportunities for this? Hematopoiesis, cancer biology, stem cells, glycans?

Honored to share our all-in-one CAR-T work for advanced prostate cancer with @zklaassen_md and @urotoday . Grateful for @PCFnews @PCF_Science , @carlhjune & my team. urotoday.com/video-lectures…

🚨 Calling all postdocs 🚨 We are soliciting applications to our 8th cohort of Fred Hutch Dr. Eddie Méndez Scholars! Awardees will be invited to present at a symposium celebrating their achievements 🧵 Apply here 👇 👇 👇 apply.interfolio.com/176955 📆 Applications due 2/1/2026

I am at #SITC25 . I’m looking for a second postdoc to join my tumor immunology lab at UCSF. So, if you’re graduating soon etc. and here, message me or drop your poster number in the comments!!

Please Repost: 3 out of 4 adults by age 30 have HPV. In the past 4 years HPV related tongue, throat & tonsil cancer has surpassed cervical cancer & become an epidemic among men between ages 40-60. Let's protect our sons and daughter by leaning about the HPV vaccine. @DrZSB @drsforamerica @DrMarcSiegel @InfoASHA @foxandfriends @ImmunizeOrg @TheJoeySwoll @EricTopol @USRepKCastor @HPVProjectPERCH @JesseBWatters @rfkJrHealth24 @SU2C

What's the difference between Trm and exhausted CD8 T cells? Simone Park's new work dissects this important question. These cell types are often confused, but are ontologically and mechanistically distinct with implications for immunotherapy responses. biorxiv.org/content/10.110…

Proud of my student, Jidapa Janpathompong, for delivering an outstanding presentation on her summer research at the SUIP Symposium at Penn. Huge thanks to everyone who made this event a success! @RTAatPennMed @parkerici @PennMedicine @bradylabupenn

📢 Just Published! Dr. Douglas’s latest research reveals how chemotherapy-induced taste changes impact nutrition and quality of life. 🔗 Read More: loom.ly/jUJKxfc (#linkinbio) #CancerResearch #SmellandTaste #QualityOfLife #NutritionMatters #Rhinology

@bayesianboy Welcome to Philly!

Moving to Philadelphia in a month. Let me know if you’re there (or in Princeton).

Boom!💥 ⁦@FDA⁩ approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, ushering in a new standard of care for the first time in decades. fda.gov/drugs/resource…

Thanks to @NIH-supported research, baby KJ successfully received personalized gene therapy treatment for CPS1, a life-threatening, incurable genetic disease. This marks the first time this technology has been successfully used to treat a human patient.

@Zhiliang_Bai @MIT @MITdeptofBE @kochinstitute Congrats Zhiliang! Can’t wait for all the great science to come from Bai lab

I’m beyond thrilled to share that I will be joining the @MIT Department of Biological Engineering @MITdeptofBE as an Assistant Professor in January 2026! I will also be an intramural member of the legendary Koch Institute for Integrative Cancer Research at MIT @kochinstitute

@AHNSinfo So proud of this tribute to my dear friend Dr. Eddie Mendez. His profound legacy lives on through the work of these fellows and our society!

The 2024 Young Investigator Awards recipients have just been announced. Congrats to this year’s class, who received $6.3 million in funding for innovative prostate cancer research. Meet this year’s class: bit.ly/YIAwardsClass2… #ProstateCancer #MedEd #MedX

Congrats to @EJohnWherry, PhD, Co-Director of the PICI Center at @PennMedicine, on his election to the @theNASciences—one of the highest honors in American science! His discoveries in T cell exhaustion and checkpoint pathways have transformed cancer immunotherapy and continue to shape the field. nasonline.org/news/2025-nas-… #Immunotherapy #CancerImmunotherapy #NASmembers

Job alert! We are looking for postdoc interested in quantitative methods to understand metabolic programming in cancer and immune cells! Also recruiting technician to help manage lab instruments and projects. DM or email me or forward to anyone you think that might be interested!

🚨Finally! @DrUppaluri presents data from Keynote0689 -- anti-PD1 makes it in locally advanced HNSCC -- approximate 10% EFS benefit from Pembro in surgically managed HNSCC. #aacr25 #hncsm

Excited to share our latest study in Biochemical Journal! We identified a novel SPOP degron in MyD88 and other substrates, featuring a new N-terminal Q-motif essential for SPOP-mediated degradation. These insights could help identify new SPOP substrates. portlandpress.com/biochemj/artic…